A Quality Assurance Program for AIDS Clinical Trials Group Pharmacology studies
The goal of the AIDS Clinical Trials Group (ACTG) Pharmacology Quality Assurance (QA) Program is to provide mechanisms that assure, in a timely manner, the validity and integrity of the data produced in pharmacology‐related ACTG research protocols. In 2000, a new QA Program for ACTG Pharmacology Stu...
Gespeichert in:
| Veröffentlicht in: | The quality assurance journal 2005-03, Vol.9 (1), p.22-30 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 30 |
|---|---|
| container_issue | 1 |
| container_start_page | 22 |
| container_title | The quality assurance journal |
| container_volume | 9 |
| creator | DiFrancesco, Robin Holland, Diane T. Schiffhauer, Joanne E. Robbins, Brian L. Tooley, Kelly M. Morse, Gene D. |
| description | The goal of the AIDS Clinical Trials Group (ACTG) Pharmacology Quality Assurance (QA) Program is to provide mechanisms that assure, in a timely manner, the validity and integrity of the data produced in pharmacology‐related ACTG research protocols. In 2000, a new QA Program for ACTG Pharmacology Studies was strategized and implemented. By identifying the common problems and errors occurring within prior clinical studies and utilizing the quality procedures inherent within Good Clinical Practice (GCP) Regulations, Good Laboratory Practice (GLP) Regulations and the Clinical Laboratory Improvement Act (CLIA), specific program components were designed. The latter regulation, CLIA, is required for ACTG Pharmacology Support Laboratories (PSL) generating laboratory results directly impacting patient care. New pharmacology QA practices were implemented throughout the conduct of ACTG clinical trials. This document provides an overview of the present ACTG Pharmacology QA program. Copyright © 2005 John Wiley & Sons, Ltd. |
| doi_str_mv | 10.1002/qaj.308 |
| format | Article |
| fullrecord | <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_qaj_308</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_L02BNGG6_2</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2098-d654a5f05e2680703ac1e3e35bfe3c9c68947ee4fd72274298287225fe1f91a93</originalsourceid><addsrcrecordid>eNp10DtPwzAUhmELgUQpiL_gjQGl-JLE9hgKhKKoF1HEaBnXLi5JU-xGkH9PqiA2pvMNj87wAnCJ0QgjRG4-1WZEET8CA4yEiDDj6fFhcxZxyvgpOAthg1BnhRiAWQYXjSrdvoVZCI1XW23g3Ndrrypoaw-zyd0zHJdu67Qq4dI7VQaY-7rZwfm78pXSdVmvWxj2zcqZcA5ObCfMxe8dgpeH--X4MSpm-WScFZEmSPBolSaxSixKDEk5YogqjQ01NHmzhmqhUy5iZkxsV4wQFhPBCe9WYg22AitBh-Cq_6t9HYI3Vu68q5RvJUby0EF2HWTXoZPXvfxypWn_Y3KRPfU66rULe_P9p5X_kCmjLJGv01wWiNxO8zyVhP4AvTxsNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Quality Assurance Program for AIDS Clinical Trials Group Pharmacology studies</title><source>Access via Wiley Online Library</source><creator>DiFrancesco, Robin ; Holland, Diane T. ; Schiffhauer, Joanne E. ; Robbins, Brian L. ; Tooley, Kelly M. ; Morse, Gene D.</creator><creatorcontrib>DiFrancesco, Robin ; Holland, Diane T. ; Schiffhauer, Joanne E. ; Robbins, Brian L. ; Tooley, Kelly M. ; Morse, Gene D.</creatorcontrib><description>The goal of the AIDS Clinical Trials Group (ACTG) Pharmacology Quality Assurance (QA) Program is to provide mechanisms that assure, in a timely manner, the validity and integrity of the data produced in pharmacology‐related ACTG research protocols. In 2000, a new QA Program for ACTG Pharmacology Studies was strategized and implemented. By identifying the common problems and errors occurring within prior clinical studies and utilizing the quality procedures inherent within Good Clinical Practice (GCP) Regulations, Good Laboratory Practice (GLP) Regulations and the Clinical Laboratory Improvement Act (CLIA), specific program components were designed. The latter regulation, CLIA, is required for ACTG Pharmacology Support Laboratories (PSL) generating laboratory results directly impacting patient care. New pharmacology QA practices were implemented throughout the conduct of ACTG clinical trials. This document provides an overview of the present ACTG Pharmacology QA program. Copyright © 2005 John Wiley & Sons, Ltd.</description><identifier>ISSN: 1087-8378</identifier><identifier>EISSN: 1099-1786</identifier><identifier>DOI: 10.1002/qaj.308</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>clinical trials ; method validation ; proficiency testing ; quality assurance ; quality improvement</subject><ispartof>The quality assurance journal, 2005-03, Vol.9 (1), p.22-30</ispartof><rights>Copyright © 2005 John Wiley & Sons, Ltd.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2098-d654a5f05e2680703ac1e3e35bfe3c9c68947ee4fd72274298287225fe1f91a93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fqaj.308$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fqaj.308$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>DiFrancesco, Robin</creatorcontrib><creatorcontrib>Holland, Diane T.</creatorcontrib><creatorcontrib>Schiffhauer, Joanne E.</creatorcontrib><creatorcontrib>Robbins, Brian L.</creatorcontrib><creatorcontrib>Tooley, Kelly M.</creatorcontrib><creatorcontrib>Morse, Gene D.</creatorcontrib><title>A Quality Assurance Program for AIDS Clinical Trials Group Pharmacology studies</title><title>The quality assurance journal</title><addtitle>Qual. Assur. J</addtitle><description>The goal of the AIDS Clinical Trials Group (ACTG) Pharmacology Quality Assurance (QA) Program is to provide mechanisms that assure, in a timely manner, the validity and integrity of the data produced in pharmacology‐related ACTG research protocols. In 2000, a new QA Program for ACTG Pharmacology Studies was strategized and implemented. By identifying the common problems and errors occurring within prior clinical studies and utilizing the quality procedures inherent within Good Clinical Practice (GCP) Regulations, Good Laboratory Practice (GLP) Regulations and the Clinical Laboratory Improvement Act (CLIA), specific program components were designed. The latter regulation, CLIA, is required for ACTG Pharmacology Support Laboratories (PSL) generating laboratory results directly impacting patient care. New pharmacology QA practices were implemented throughout the conduct of ACTG clinical trials. This document provides an overview of the present ACTG Pharmacology QA program. Copyright © 2005 John Wiley & Sons, Ltd.</description><subject>clinical trials</subject><subject>method validation</subject><subject>proficiency testing</subject><subject>quality assurance</subject><subject>quality improvement</subject><issn>1087-8378</issn><issn>1099-1786</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp10DtPwzAUhmELgUQpiL_gjQGl-JLE9hgKhKKoF1HEaBnXLi5JU-xGkH9PqiA2pvMNj87wAnCJ0QgjRG4-1WZEET8CA4yEiDDj6fFhcxZxyvgpOAthg1BnhRiAWQYXjSrdvoVZCI1XW23g3Ndrrypoaw-zyd0zHJdu67Qq4dI7VQaY-7rZwfm78pXSdVmvWxj2zcqZcA5ObCfMxe8dgpeH--X4MSpm-WScFZEmSPBolSaxSixKDEk5YogqjQ01NHmzhmqhUy5iZkxsV4wQFhPBCe9WYg22AitBh-Cq_6t9HYI3Vu68q5RvJUby0EF2HWTXoZPXvfxypWn_Y3KRPfU66rULe_P9p5X_kCmjLJGv01wWiNxO8zyVhP4AvTxsNA</recordid><startdate>200503</startdate><enddate>200503</enddate><creator>DiFrancesco, Robin</creator><creator>Holland, Diane T.</creator><creator>Schiffhauer, Joanne E.</creator><creator>Robbins, Brian L.</creator><creator>Tooley, Kelly M.</creator><creator>Morse, Gene D.</creator><general>John Wiley & Sons, Ltd</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200503</creationdate><title>A Quality Assurance Program for AIDS Clinical Trials Group Pharmacology studies</title><author>DiFrancesco, Robin ; Holland, Diane T. ; Schiffhauer, Joanne E. ; Robbins, Brian L. ; Tooley, Kelly M. ; Morse, Gene D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2098-d654a5f05e2680703ac1e3e35bfe3c9c68947ee4fd72274298287225fe1f91a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>clinical trials</topic><topic>method validation</topic><topic>proficiency testing</topic><topic>quality assurance</topic><topic>quality improvement</topic><toplevel>online_resources</toplevel><creatorcontrib>DiFrancesco, Robin</creatorcontrib><creatorcontrib>Holland, Diane T.</creatorcontrib><creatorcontrib>Schiffhauer, Joanne E.</creatorcontrib><creatorcontrib>Robbins, Brian L.</creatorcontrib><creatorcontrib>Tooley, Kelly M.</creatorcontrib><creatorcontrib>Morse, Gene D.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><jtitle>The quality assurance journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DiFrancesco, Robin</au><au>Holland, Diane T.</au><au>Schiffhauer, Joanne E.</au><au>Robbins, Brian L.</au><au>Tooley, Kelly M.</au><au>Morse, Gene D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Quality Assurance Program for AIDS Clinical Trials Group Pharmacology studies</atitle><jtitle>The quality assurance journal</jtitle><addtitle>Qual. Assur. J</addtitle><date>2005-03</date><risdate>2005</risdate><volume>9</volume><issue>1</issue><spage>22</spage><epage>30</epage><pages>22-30</pages><issn>1087-8378</issn><eissn>1099-1786</eissn><abstract>The goal of the AIDS Clinical Trials Group (ACTG) Pharmacology Quality Assurance (QA) Program is to provide mechanisms that assure, in a timely manner, the validity and integrity of the data produced in pharmacology‐related ACTG research protocols. In 2000, a new QA Program for ACTG Pharmacology Studies was strategized and implemented. By identifying the common problems and errors occurring within prior clinical studies and utilizing the quality procedures inherent within Good Clinical Practice (GCP) Regulations, Good Laboratory Practice (GLP) Regulations and the Clinical Laboratory Improvement Act (CLIA), specific program components were designed. The latter regulation, CLIA, is required for ACTG Pharmacology Support Laboratories (PSL) generating laboratory results directly impacting patient care. New pharmacology QA practices were implemented throughout the conduct of ACTG clinical trials. This document provides an overview of the present ACTG Pharmacology QA program. Copyright © 2005 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><doi>10.1002/qaj.308</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1087-8378 |
| ispartof | The quality assurance journal, 2005-03, Vol.9 (1), p.22-30 |
| issn | 1087-8378 1099-1786 |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_qaj_308 |
| source | Access via Wiley Online Library |
| subjects | clinical trials method validation proficiency testing quality assurance quality improvement |
| title | A Quality Assurance Program for AIDS Clinical Trials Group Pharmacology studies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T15%3A25%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Quality%20Assurance%20Program%20for%20AIDS%20Clinical%20Trials%20Group%20Pharmacology%20studies&rft.jtitle=The%20quality%20assurance%20journal&rft.au=DiFrancesco,%20Robin&rft.date=2005-03&rft.volume=9&rft.issue=1&rft.spage=22&rft.epage=30&rft.pages=22-30&rft.issn=1087-8378&rft.eissn=1099-1786&rft_id=info:doi/10.1002/qaj.308&rft_dat=%3Cistex_cross%3Eark_67375_WNG_L02BNGG6_2%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |